2-Fluoropyridine prosthetic compounds for the 18F labeling of bombesin analogues

被引:13
作者
Inkster, James [1 ,2 ]
Lin, Kuo-Shyan [3 ]
Ait-Mohand, Samia [4 ]
Gosselin, Simon [4 ]
Benard, Francois [3 ]
Guerin, Brigitte [4 ]
Pourghiasian, Maral [3 ]
Ruth, Thomas [1 ,3 ]
Schaffer, Paul [1 ]
Storr, Tim [2 ]
机构
[1] TRIUMF, Div Nucl Med, Vancouver, BC V6T 2A3, Canada
[2] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada
[3] British Columbia Canc Agcy, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada
[4] Univ Sherbrooke, Dept Nucl Med & Radiobiol, Sherbrooke, PQ J1H 5N4, Canada
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
Bombesin; Positron emission tomography; Fluorine-18; CuAAC chemistry; Neuropeptides; GASTRIN-RELEASING-PEPTIDE; IN-VIVO EVALUATION; NUCLEOPHILIC AROMATIC-SUBSTITUTION; CLICK CHEMISTRY; HUMAN PROSTATE; HIGH-AFFINITY; BREAST-CANCER; MOUSE MODEL; RECEPTOR; GRP;
D O I
10.1016/j.bmcl.2013.04.060
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Acetylene-bearing 2-[F-18]fluoropyridines [F-18]FPy5yne and PEG-[F-18]FPyKYNE were prepared via efficient nucleophilic heteroaromatic [F-18]fluorination of their corresponding 2-trimethylammoniumpyrdinyl precursors. The prosthetic groups were conjugated to azide- and PEG(3)-modified bombesin(6-14) analogues via copper-catalyzed azide-alkyne cycloaddition couplings to yield mono- and di-mini-PEGylated ligands for PET imaging of the gastrin- releasing peptide receptor. The PEG(3)- and PEG(2)/PEG(3)-bearing F-18 peptides showed decreased lipophilicity relative to an analogous non-mini-PEGylated F-18 peptide. Assessment of water-soluble peptide pharmacokinetics and tumour-targeting capabilities in a mouse model of prostate cancer is currently underway. (c) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3920 / 3926
页数:7
相关论文
共 65 条
  • [31] Kuhnast B, 2009, J LABELLED COMPD RAD, V52, pS184
  • [32] [18F]FPyKYNE, a fluoropyridine-based alkyne reagent designed for the fluorine-18 labelling of macromolecules using click chemistry
    Kuhnast, Bertrand
    Hinnen, Francoise
    Tavitian, Bertrand
    Dolle, Frederic
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2008, 51 (9-10) : 336 - 342
  • [33] A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent
    La Bella, R
    Garcia-Garayoa, E
    Bähler, M
    Bläuenstein, P
    Schibli, R
    Conrath, P
    Tourwé, D
    Schubiger, PA
    [J]. BIOCONJUGATE CHEMISTRY, 2002, 13 (03) : 599 - 604
  • [34] 99mTc(CO)3-DTMA bombesin conjugates having high affinity for the GRP receptor
    Lane, Stephanie R.
    Veerendra, Bhadrasetty
    Rold, Tammy L.
    Sieckman, Gary L.
    Hoffman, Timothy J.
    Jurisson, Silvia S.
    Smith, Charles J.
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2008, 35 (03) : 263 - 272
  • [35] Targeting Somatostatin Receptors: Preclinical Evaluation of Novel 18F-Fluoroethyltriazole-Tyr3-Octreotate Analogs for PET
    Leyton, Julius
    Iddon, Lisa
    Perumal, Meg
    Indrevoll, Bard
    Glaser, Matthias
    Robins, Edward
    George, Andrew J. T.
    Cuthbertson, Alan
    Luthra, Sajinder K.
    Aboagye, Eric O.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (09) : 1441 - 1448
  • [36] Li Z. B., 1987, BIOCONJUGATE CHEM, V2007, P18
  • [37] 18F-labeled BBN-RGD heterodimer for prostate cancer imaging
    Li, Zi-Bo
    Wu, Zhanhong
    Chen, Kai
    Ryu, Eun Kyoung
    Chen, Xiaoyuan
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (03) : 453 - 461
  • [38] A new high affinity technetium-99m-bombesin analogue with low abdominal accumulation
    Lin, KS
    Luu, A
    Baidoo, KE
    Hashemzadeh-Gargari, H
    Chen, MK
    Brenneman, K
    Pili, R
    Pomper, M
    Wagner, HN
    [J]. BIOCONJUGATE CHEMISTRY, 2005, 16 (01) : 43 - 50
  • [39] Click for PET:: rapid preparation of [18F]fluoropeptides using CuI catalyzed 1,3-dipolar cycloaddition
    Marik, Jan
    Sutcliffe, Julie L.
    [J]. TETRAHEDRON LETTERS, 2006, 47 (37) : 6681 - 6684
  • [40] Markwalder R, 1999, CANCER RES, V59, P1152